Powers Principals William van Oehsen, Peggy Tighe, and Barbara Straub Williams, and Powers Associate Shuchi Parikh spoke at the first-ever Ryan White Clinics (RWC) 340B National Conference in Chattanooga, Tennessee on August 1st.
Powers Associate Leela Baggett will present on the enforcement of Medicare enrollment requirements on Monday, November 5, 2018.
Powers Principal Barbara Straub Williams will present on 340B drug pricing program compliance at the Health Care Compliance Association’s (“HCCA’s”) Healthcare Enforcement Compliance Conference in Washington, DC on Tuesday, November 6, 2018.
Powers Associate Shuchi Parikh will present on the 340B Drug Pricing Program at a D.C. Bar Health Law Community event on September 26.Read More
A bipartisan letter sent earlier this week by the leadership of the Senate and House committees with oversight of the 340B Program reflects both Congressional resolve to keep a focus on the program and potentially a shifting battlefield regarding potential changes in the 340B Program at the close of 2018 and entering 2019. Read More
Powers Principal William von Oehsen contributed the legal analysis to a recent article discussing drug purchasing strategies that could lower drug prices for treating Hepatitis C patients within the criminal justice system.Read More
Powers 340B attorneys William von Oehsen, Barbara Williams and Shuchi Parikh presented on a range of topics at the 340B Coalition Summer Conference in July, including preparation for HRSA audits, when and how to self-report and to take corrective action, understanding Medicare cost reports and application of Medicaid billing and reimbursement policies to 340B drugs.Read More
Powers Principals William von Oehsen and Barbara Williams and Associate Shuchi Parikh co-wrote a chapter of The 340B Program Handbook, a comprehensive guide on the 340B drug discount program recently published by the American Society of Health System Pharmacists.Read More
Powers Principal William von Oehsen spoke about changes to the 340B program and how these modifications could affect covered entities at the 12th Annual “Big 4” Pharmaceutical Pricing Boot Camp in New York City last week.Read More
